- $39.69bn
- $47.39bn
- $10.51bn
- 85
- 38
- 72
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,495 | 4,667 | 7,473 | 11,324 | 10,511 |
Cost of Revenue | |||||
Gross Profit | 4,575 | 3,607 | 5,267 | 7,741 | 7,563 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5,909 | 7,186 | 5,612 | 7,531 | 7,696 |
Operating Profit | 586 | -2,519 | 1,861 | 3,793 | 2,815 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 221 | -2,850 | 1,490 | 3,546 | 2,471 |
Provision for Income Taxes | |||||
Net Income After Taxes | -240 | -2,839 | 890 | 2,447 | 1,738 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -408 | -3,093 | 559 | 2,096 | 1,382 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -412 | -3,093 | 559 | 2,096 | 1,382 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.42 | -5.8 | 2.04 | 6.67 | 4.68 |
Dividends per Share |